✦ LIBER ✦
A prospective, open-label treatment trial to compare the effect of IFN -1a (Avonex(R)), IFN -1b (Betaseron(R)), and glatiramer acetate (Copaxone(R)) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy
✍ Scribed by Khan, O. A; Tselis, A. C; Kamholz, J. A; Garbern, J. Y; Lewis, R. A; Lisak, R. P
- Book ID
- 119971795
- Publisher
- SAGE Publications
- Year
- 2001
- Tongue
- English
- Weight
- 95 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1352-4585
No coin nor oath required. For personal study only.